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Haloproginis a topical antifungal agent. Its structuredoes not contain any of the functional 
groups typically exploited in hydrogen bond based co-crystal design. On the other hand, its  1-
iodoalkyne moiety is nicely tailored to a crystal engineering strategy based on halogen 
bonding.  Here we describe the formation of threepolymorphs of haloprogin and of threeco-
crystalsthat this active pharmaceutical ingredient forms with both neutral and ionic co-crystal 
formers.  The halogen bond plays a major role in all of the six structures and the interaction is 
thus confirmed to be a valuable tool which may complement the hydrogen bond when 
polymorph and co-crystal screeningsare pursued. 
 
Introduction 
Polymorph and co-crystal screeningsareuseful strategies to find 
new solid forms of active pharmaceutical ingredients(APIs),in 
order to alter/improve their physical properties without 
changing their chemical identities or biological activities.1Most 
commonly APIs have hydrogen bonding donor and acceptor 
groups that are involved in the binding of the co-crystal former 
(CCF), e.g., carboxylic acids and aromatic nitrogen atoms 
havebeen proven particularly reliable moieties in hydrogen 
bonding (HB) driven formation of API-CCF adducts.2On the 
other hand, the design of pharmaceutical co-crystals involving 
APIs devoid of strong hydrogen bonddonor sitesisquite 
challenging.  
 Halogen atoms are frequently present in drugs molecules 
and we considered that they can be used to drive the formation 
of pharmaceutical co-crystals if the halogen bonding3(XB) is 
used.  Recently we demonstrated that the iodoalkyne moiety of 
an API can be successfully used to prepare halogen-bonded co-
crystalswith improved physicochemical properties.4In this 
paper we describe a further case where the same moiety drives 
the formation of co-crystals with neutral and anionic partners.  
More important, we describe how the iodoalkyne moiety can 
play an active role in the formation of different polymorphs of 
an API. 
 Haloprogin1(1,2,4-trichloro-5-[(3-iodoprop-2-yn-1-
yl)oxy]benzene) is the API of antimycotic topical drugswith 
brand names of Halotex®, Mycanden®, Mycilan® and Polik® 
(Scheme 1).5No structures involving 1are reported in the 
Cambridge Structural Database (CSD),6 consistent with the fact 
that it may represent a difficult challenge if a standard approach 
for polymorph and co-crystal formation is pursued since it does 
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Scheme 1.Molecular structures of Haloprogin and of the used CCFs. The 
used atom labels are indicated for all structures. Torsion angles 1and 2 are 
indicated with curved arrows. 
 On the other hand, an iodine atom bound to the sp-
hybridisedcarbon atom displays a particularly anisotropic 
distribution of its electron density.7 A region of remarkably 
positive electrostatic potential, the so-called positive -hole,8is 
present on the outermost surface of the iodine atom and along 
the extension of the C-I covalent bond.This specific feature 
makes the iodoalkynemoiety a very good XB donorsite.9,10We 
reasoned that the presence in 1of one efficient XBdonor 
sitealong with the absence of strong HBdonor sites represents a 
unique opportunity to explore the obtainment of new co-
crystals based on XB.In addition, the presence in 1of multiple 
electrondonor sites that may be involved in XB, e.g., the 
 
2 
chlorine atoms, the oxygen atom, and the  electrons, may 
favour the obtainment of different polymorphs and allow for a 
quite rich structural landscape for the pure API. 
 Three polymorphs 1a, 1b, and 1cof haloprogin are 
described here.As far as co-crystals of 1are concerned, we 
obtained a neutral co-crystal 4with 4,4’-bipyridine (2) and two 
ionic co-crystals 5aand 5bwith tetran-butylammonium iodide 
(3a) and chloride (3b).11The studied CCFs were chosen in order 
to cover both neutral and anionic electron densitydonor 
sites,which are both well represented in the FDA-GRAS12(Food 
and Drug Administration-Generally Recognized As Safe) 
list.All obtained solid forms of 1(polymorphs and co-crystals) 
were fully characterized by using various analyticaltechniques, 
such as single-crystal and powder X-ray diffraction analyses, 





Solvents and reagents were purchased from Sigma Aldrich at 
high purity grade and used without further purification. 
haloprogin was synthesized in two steps according to the 
procedure reported by Fellig et al.13 (see ESI). Solution NMR 
spectra were collected on a Bruker AV400 spectrometer. Single 
crystals of polymorphs 1a and 1b were obtained by slow 
evaporation methods.  Single crystals of polymorphs1b and 1c 
were obtained viaboth slow evaporation and sublimation.Co-
crystalsof 4were obtained by slow evaporation methods. 
Mechanochemical synthesis of 5aand 5bwas performed using a 
Retsch MM400 ball mill with 5.0 mL vessels, operating at 30 
Hz.  Correspondingsingle crystals were obtained by seeding 
quasi-saturated solutions of 1and 3aor 3b, respectively (in the 
appropriate molar ratio) with the powders obtained from ball 
milling experiments.  
Vibrational Spectroscopy. IR spectra were collected using a 
Nicolet Nexus FT-IR spectrometer equipped with Smart 
Endurance ATR device, and analysed using Omnic software 
v.7.3. Peak values are given in wavenumbers (cm-1) upon 
automatic assignment.  
Thermal Analysis.Melting points were collected using a 
Linkam Hot-Stage microscopy apparatus. Thermal analysis was 
performed on a Mettler Toledo DSC 823e differential scanning 
calorimeter. 
X-ray Crystallography.A Bruker AXS D8 powder 
diffractometer was used for all X-ray powder (XRPD) 
measurements with experimental parameters are as follows: 
Cu-K  radiation (λ = 1.54056 Å), scanning interval: 4-40° 2θ. 
Step size 0.016°, exposure time 1.5 s/step. Single crystal X-ray 
diffraction (XRD) data were collected on a Bruker AXS 
KAPPA-APEX II CCD diffractometer using Mo-Kα radiation 
(λ = 0.71073 Å). Data integration and reduction were 
performed using SaintPlus 6.01.14Absorption correction was 
performed with a multi-scan method implemented in 
SADABS.15Space groups were determined using XPREP 
implemented in APEX II suite.16Structures were solved using 
SHELXS-97 (direct methods) and refined using SHELXL-9717 
(full-matrix least-squares on F2) contained in APEX II and 
WinGX v1.80.01software packages.18All non-hydrogen atoms 
were refined anisotropically. Hydrogen atoms were placed in 
geometrically calculated positions and included in the 
refinement process using a riding model with isotropic thermal 
parameters. Analysis of crystal data and pictures were 
performed with Mercury 3.1.19Crystal data are reported in 
Table 1. 
Solid state NMR.SSNMR measurements were run on a Bruker 
AVANCE II 400 instrument operating at 400.23, 100.65 and 
40.55 MHz for 1H, 13C and 15N, respectively. 13C and 15N 
CPMAS spectra were recorded at room temperature at the 
spinning speed of 12 (13C) or 9 kHz (15N). Cylindrical 4mm o.d. 
zirconia rotors with sample volume of 80 µL were employed. A 
ramp cross-polarization pulse sequence was used with contact 
times of 5 ms, a 1H 90° pulse of 3.30 µs, recycle delays of 10-
40 s, and 512-4096 (13C) or 1400-1600 (15N) transients. The 
two pulse phase modulation (TPPM) decoupling scheme was 
used with a frequency field of 75 kHz. Spectral editing 
experiments were performed by using a CPPISPI pulse 
sequence with a polarization inversion time of 65-85 s in order 
to obtain CH3 and Cq positive, CH null, and CH2 negative.
13C 
and 15N scales were calibrated with glycine (13C methylene 
signal at 43.86 ppm) and (NH4)2SO4 (
15N signal at δ=355.8 
ppm with respect to CH3NO2) as external standards.
13C and 15N 
chemical shift assignment for pure reagents and for the co-
crystals are in the SI.Atom labels used in SSNMR studies are 
reported in the Scheme 1. Spectral editing techniques were 
useful for unambiguous assignments.All 13C and 15N chemical 
shifts with assignments are reported in the Table S1 in the ESI. 
 
Conformational and computational analysis.The 
conformational comparison was performed overlapping the 
aromatic portions of the three polymorphs of1. Energy 
calculations were performed at MP2/6-311+G(d,p) level of 
theory within Spartan Software.20The molecular geometry 
obtained by X-ray studies was used for these analysis.  
 
Preparation of polymorphs and co-crystals 
Synthesis of polymorph 1a:In a 2.5 mL glass vial, 10 mg of 1 
(0.027 mmol) were dissolved in 1.5 mL of chloroform. The 
open vial was left in the hood at room temperature and after 17 
hours clear colourless octahedral crystals of 1awere foundat the 
bottom of the vial,. M.p.: 111 °C. FTIR (selected bands): 2187, 
1581, 1472, 1453, 1232, 1077, 1028, 866, 724, 681 cm-1. 
Syntheses of polymorphs 1b and 1c: In a 2.5 mL glass vial, 
11.7 mg of 1 (0.032 mmol) were dissolved in 1.0 mL of 
chloroform, then a solution of sodium acetate (2.9 mg, 0.032 
mmol) in methanol (1.0 mL) was stratified on top of the 
solution of1. The vial was capped and the solvents slowly 
evaporatedthrougha needle in the cap.  
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Table 1. Crystallographic data for polymorphs 1a-c and co-crystals4 and 5a,b. 
 
 1a 1b 1c 4 5a 5b 
Chemical Formula        C9H4Cl3IO C9H4Cl3IO C9H4Cl3IO C28H16Cl6I2N2O2 C34H44Cl6I3NO2 C34H44Cl7I2NO2 
Formula weight                                               361.37 361.37 361.37 878.93 1092.10 1000.65 
Temperature K 295 296 296 296 296 103 
Crystal system Monoclinic Triclinic Monoclinic Triclinic Orthorhombic Orthorhombic 
Space group                                                                       C2/c P-1 C2/c P-1 Pbcn Pbcn 
a (Å) 22.173(2) 4.2659(6) 31.100(5) 7.4865(14) 8.9174(9) 8.557(2) 
b (Å) 7.6870(7) 10.4936(14) 5.3807(7) 13.522(3) 15.2187(12) 14.816(3) 
c (Å) 13.8308(13) 13.3814(16) 13.861(2) 17.240(3) 31.429(3) 31.189(6) 
(°) 90.00 108.226(12) 90 67.769(9) 90.00 90.00 
β (°) 109.181(4) 93.893(12) 107.050(5) 81.362(9) 90.00 90.00 
(°) 90.00 90.291(12) 90 79.166(9) 90.00 90.00 
Volume (Å3) 2226.5(4) 567.43(13) 2217.5(6) 1580.7(5) 4265.3(7) 3954.2(14) 
Z 8 2 8 2 4 4 
Density (gcm-3) 2.156 2.115 2.159 1.847 1.701 1.681 
μ (mm-1) 3.588 3.490 3.572 2.526 2.603 2.095 
F (000) 1360 340 1352 844 2128 1984 
ABS Tmin, Tmax 0.6548, 0.7465 0.5823, 0.7452 - 0.4510, 0.9125 0.3943, 0.5199 0.5999, 0.7458 
θmin, max (°) 1.94, 32.86 1.61, 27.75 2.74, 24.99 1.28, 32.32 2.59, 29.25 2.72, 38.01 
hmin, max -32, 25 -5, 5 -31, 32 -10, 10 -12, 12 -13, 14 
kmin, max -10, 11 -13, 13 -6, 6 -20, 16 -20, 20 -25, 23 
lmin, max -21, 21 -16, 16 -16, 9 -24, 24 -42, 43 -51, 51 
No. of reflections. 15765 13209 2364 30410 61875 91960 
No. unique reflections. 3779 2461 1634 9602 5811 10012 
No of parameter                                                                       127 127 128 361 211 211 
R_all, R_obs  0.0452, 0.0366 0.0385, 0.0314 0.1436, 0.1236 0.0546, 0.0303 0.0524, 0.0341 0.0405, 0.0267 
wR2_all, wR2_obs 0.1082, 0.1035 0.0785, 0.0737 0.2992, 0.2744 0.0733, 0.0633 0.0869, 0.0736 0.0537, 0.0497 
∆ρmax, min (eÅ
-3)                                                                    -1.001, 1.126 -0.993, 0.609 -1.631, 4.982 -0.482, 0.713 -0.858, 1.013 -1.766, 1.237 
G.o.F 1.058 1.059 1.044 1.004 1.079 1.086 
CCDC 986303 986304 986305 986300 986302 986301 
 
 
After two days, needles of 1b and few small needles of 
1cappeared along with many crystals of 1a. 1a,1b, and 1cwere 
separated by visual inspection. M.p.s: 1b, 113°C; 1c, 91°C; 
FTIR of 1b (selected bands): 3100, 2928, 2186, 1582, 1471, 
1335, 1233, 1077, 867, 725 cm-1.  
Synthesis of polymorphs1b and 1cby sublimation:The crude 
powdered 1a was sublimated at 80°C under vacuum (P ~20 
mbar).  After 10 hours, a mixture of 1band 1ccrystals were 
collected on a glass slide fixed to the water cooled 
condenser.The 1c crystals completely transformed into 
polycrystalline1aon standing at room temperature. 
Synthesis of 4 (Haloprogin:bipyridyl,2:1ratio):In a 10 mL 
glass vial 400 mg (1.106mmol) of 1 were dissolved in 5.0 mL 
of dichloromethane, then a solution of 4,4’-bipyridyl (84.7 mg, 
0.553 mmol) in 2.= mL of dichloromethane was added. The 
open vial was left in the hood at room temperature. After three 
days, several yellowish prisms appeared at the bottom and on 
the walls of the vial. M.p.: 118°C; FTIR (selected bands): 3096, 
2178, 1620, 1473, 1336, 1078, 1026, 801, 723, 614 cm-1. 
Synthesis of 5a (Haloprogin:tetra n-butylammonium 
iodide,2:1ratio):200 mg of 1(0.553mmol) and 102 mg of 
tetran-butylammonium iodide (0.277mmol) were ground 
together in a high-speed ball milling apparatus for 30min at 
30Hz. Powders were collected and analyzed by FTIR, XRPD, 
and DSC. M.p.: 67°C; FTIR (selected bands): 2957, 2872, 
2180, 1585, 1473, 1377, 1240, 1077, 1033, 764 cm-1. Single 
crystals were obtained by seeding a quasi-saturated solution of 
1 and 3a (2:1 molar ratio) in methanol with the finely ground 
powders obtained from the solid-state synthesis and then 
allowing for the slow evaporation of thesolvent at room 
temperature. 
Synthesis of 5b (Haloprogin:tetra n-butylammonium 
chloride,2:1ratio):500 mg of 1 (1.383mmol) and 192 mg of 
tetran-butylammonium chloride (0.692mmol) were ground 
together in a high-speed ball milling apparatus for 30min at 
30Hz. The resulting powder was collected and analyzed by 
FTIR, XRPD, and DSC. M.p.: 82°C; FTIR (selected bands): 
2960, 2872, 2176, 1474, 1350, 1241, 1078, 1031, 875, 681 cm-
1. Single crystals were obtained by seeding a quasi-saturated 
solution of 1 and 3b (2:1 molar ratio) in methanol with the 
finely ground powder obtained from the solid-state synthesis 





Results and discussion 
Polymorph screening 
The crystal structure of 1 is unknown andit was expected that 
different polymorphs may be formed as several electron-donor 
sites, i.e., oxygen, chlorine, and -systems, can accept XB from 
the iodoalkyne moiety. Severalcrystallization conditions were 
thus employed in order to explore the structural landscape of 1 
and obtain different polymorphic forms. 
 Slow evaporation of a chloroform solution of 1 afforded 
polymorph 1a as octahedral crystals with m.p. of 111 °C.  The 
single crystal X-ray analysis revealed that XBplays a role in the 
structure of 1a(Figure 1, top). In fact, the iodine atom functions 
as theXB-donor andforms a short contact with the π-electron 
density of the triple bond, working as the XBacceptor, of 
another molecule of haloprogin (symmetry operation ½-
x,½+y,½-z). An infinite halogen-bonded chain is formedand 
propagates parallel to the crystallographic b axis (Figure 1, 
mid). The supramolecular chains of haloprogin molecules 
display a zig-zag arrangement with the I1∙∙∙C*∙∙∙I1i (i = ½-
x,½+y,½-z) angle of 85.2°, C* being the centroid of the triple 
bond. The C*∙∙∙I1idistance is 3.556(3) Å (C2∙∙∙I1i and 
C1∙∙∙I1idistances are 3.560(3) Å and 3.649(3) Å, respectively), 
while the C1–I1∙∙∙C* angle is 148.3(2)°. It should be noted here 
that these geometrical parameters are slightly longer and less 
linear than those found in similar supramolecular synthons 
reported in the CSD(see ESI).21 -  Stacking interactions 
between couples of anti-parallel aromatic rings are also present 
with a separation of the rings centroids of 3.831Ǻ (Figure 1, 
bottom).  
 Looking for other polymorphic forms of 1, several organic 
solvents and their combinations were explored.  All 
experiments resulted in the exclusive formation of 
polymorph1a (see ESI) but when the ionic strength of the 
crystallization medium was drastically increased. In fact, when 
a chloroform solution of haloprogin was allowed to slowly 
diffuse into a saturated methanol solution of sodium acetate and 
the resulting solvents mixture was slowly evaporated at room 
temperature (two days), some crystals oftwo 
newpolymorphs,1band1c, were obtained along with massive 
quantities of 1a. Specifically, some rectangular needle-like 
crystals (1b, m.p.: 113 °C)and a few long and tiny needles (1c, 
m.p. 91 °C) were formed together with larger amounts of 1a 
(octahedral crystals, m.p. 111 °C).  Interestingly, a similar 
mixed phase was also obtained by sublimating powdersof 1a. 
 Single-crystal X-ray analyses demonstrated that 1a, 1b, and 
1c present quite different patterns of XBs.  In polymorph 1b, 
the iodine atom works as XB donor sites, similar to 1a, but the 
XB acceptor site is the para positioned chlorine atom of its 
centrosymmetric molecule which present the same XB pattern 
and a cyclic dimer is formed (Figure 2, top left).  The I∙∙∙Cl 
distance is 3.633(2) Å(0.97% of the sum of van der Waals 
radii22(svdWr) of involved atoms) and the C–I∙∙∙Cl and I∙∙∙Cl–








Figure 1.Top:XBs between the iodine atom and the  electrons of the triple 
bond in 1a. Mid:  supramolecular zig-zag and halogen-bonded chain.  
Bottom:  antiparallel -  stacking of 1 molecules involving the aromatic 
portions of two haloprogin molecules.  XBs are black dotted lines. The triple 
bond centroid is indicated with a transparent red dot and the symbol C*. 





















Figure 2.Structural motifs present in polymorph 1b.  “Head to tail” 
dimersoriginated by two I∙∙∙Cl XBs (top left, XBs as black lines) and two 
H∙∙∙Cl HBs (top right, HBs as magenta lines). Infinite chain formed by 
halogen and hydrogen bonds.  Label for equivalent position: i (1-x, 1-y, 2-z) 
and ii (1-x, 1-y, 1-z). Colour code of atoms as in Figure 1. 
 
These two angles are perfectly in line with the anisotropic 
electrostatic potentials around halogen atoms, with the iodine 
atom interacting through its electron poor -hole and the 
chlorine atom through its electron rich equatorial belt.  Some 
other short contacts are present in this polymorph. Two HBs 
bridge two adjacent haloprogin molecules by connecting the 
chlorine atom of one molecule to one of the methylene 
hydrogens of another molecule (H3B∙∙∙Cl1 distance is 2.82 Å, 
0.96% of svdWr of involved atoms) and hydrogen-bonded 
cyclic dimers are formed (Figure 2, top right).  Halogen and 
hydrogen-bonded cyclic dimers are connected in the overall 
crystal packing of polymorph 1band produce ribbons extending 
along the c-axis (Figure 2, bottom).  
 It seemsthat crystalsof polymorph 1care quite unstableas, at 
room temperature, theyconvert into a powder sample of 1a. As 
a consequence, the collection of a complete crystallographic 
data set was not possible but the obtained data were enough to 
refine the crystal structure and have essential structural 
information (Table 1).Similar to polymorphs 1a and 1b,also the 
crystal structure of 1cpresentsXBs whichare here the only 
noncovalent interactions below the svdWrof involved atoms. 
The iodine atom functions as a bifurcated XBdonor and 
interactsboth with the oxygen atom and with the chlorine atom 
ortho to the propargyl ether moiety(Figure 3, left). The 
I1∙∙∙Cl1ii(ìì=1-x.1+y,1/2-z) distance is 3.442(4) Å (0.92the 
svdWr of involved atoms) and the C1–I1∙∙∙Cl1ii angle is 
168.8(3)°, while the I1∙∙∙O1ii distance is 3.448(10) Å (0.98 the 
svdWr of interacting atoms) and the C1–I1∙∙∙O1ii angle is 
141.7(4)°.  These geometrical parameters closely resemble 
thosereported in the literaturefor bifurcated XBs23 where one 
XB contact is commonly shorter and more linear than the other. 
The propagation of this XB synthon results in infinite helical 


















Figure 3.Left: the bifurcated XB motifpresent in 1c. Colour code as in Figure 
1.Right: two helical chains, two different colours are used to highlight the 
different rotation of the chains.  
 Computational studies provided interesting pieces of 
information on the relative stabilities of the conformations 
adopted by molecule 1 in the three polymorphs. 1Hasfew 
degrees of conformational freedom which can be identified by 
the two torsion angles 1(C3-O1-C4-C5)and 2(C2-C3-O1-C4) 
(Scheme 1). The superposition of the aromatic rings of 
molecules 1in the conformations adopted in the three obtained 
polymorphs shows how in 1a and 1b the molecular geometry is 
almost identical with the two torsion angles that are very 















Figure 4.Comparison of the molecule conformations in the three  
polymorphs 1a-c.  The torsion angles 1 and 2 are reported.  Colour code: 
1a, blue,1b, red, and 1c, yellow.  
 
 On the contrary, the haloprogin molecule in the polymorph 
1c adopts a quite different conformation as shown in the Figure 
4, right.  Single point calculations (MP2/6-311+G(d,p)) on the 
X-ray molecular structures of the three polymorphsof 
haloprogin revealed that the conformation adopted in 1a is the 















conformation of 1c is the least stable (17.1 kJ/mol less stable 
than 1a). 
 These calculations and the similarity of the respective 
melting points, may suggest that polymorphs1a and 1b are 
energetically similar although their intermolecular networksare 
different.The form 1a is quasi-exclusively obtained in the 
crystallization experiments and this may suggest that, in spite of 
the fact that inany haloprogin molecule there are three chlorine 
atoms versus one triple bond, the I∙∙∙  synthon is more 
favouredthan the I∙∙∙Cl one.  Definitely, the polymorph 1c is the 
least stable in the conditions used, as demonstrated by the small 
obtainable amount and by the fact that it converts into 1a with 
time at room temperature. 
 
Co-crystal screening 
The iodoalkynyl moiety being a robust XB donor,7-10 we have 
investigated the formation of co-crystals involving 1andboth 
neutral and anionic electron density donor partners.  Here 
wedescribe the adducts 4 and 5a,b obtained when 4,4’-
bipyridine (2) andtetrabutylammonium iodide (3a) or chloride 
(3b) are used as XB acceptors. 
 4Was obtained by slow evaporation of a 2:1 mixture of the 
two starting materials1 and 2 dissolved in methanol.The DSC 
thermogram suggested the formation of a new supramolecular 
entity since it showed a singleand sharp melting endotherm at 
118 °C, i.e., higher than the melting points of the starting 
compounds (2m.p.: 109-112 °C).FTIR analysis confirmed that 
the supramolecular adduct formation involves the iodoalkynyl 
group, since the stretching band of the C≡C bond is at 2187 cm-
1in 1aand at 2178 cm-1 in the adduct 4.This red shiftclearly 
indicatesthat the iodine atom is halogen-bonded to a strong 














Figure 5.XBs(black dotted lines) and type I chlorine-chlorine interactions 
(red dotted lines) in the co-crystal 4.  Label for equivalent position: iii(-x, 1-
y, -z). Colour code:  blue, nitrogen; other colours as in Figure 1. 
 
 The single crystal XRD analysis confirmed the formation of 
a 2:1 complex in which the molecule of 2 functions as a ditopic 
XB acceptor and interacts at either endings with two distinct 
molecules of 1thanks to I∙∙∙N XBs (Figure 5).  The asymmetric 
unit is composed by two almost identical but independent XB 
donor molecules bound to the same bipyridine unit.  Both the 
XBs are extremely short, linear, and similar in their geometrical 
parameters.  I∙∙∙N Distances are 2.813(3) Å for I1A∙∙∙N1 and 
2.889(3) Å for I1B∙∙∙N2 (around 80% reduction of the svdWr of 
the interacting atoms) and angles C1A–I1A···N1 and C1B-
I1B···N2 are 177.95(10)° and 177.84(10)°, respectively. 
 The crystal lattice of the 4adduct is also stabilised by other 
noncovalent interactions, most relevant the type-I halogen-
halogen contacts occurring between two chlorine atoms 
[Cl3B Cl3Biii (iii=-x,1-y,1-z), distance 3.320(2) Ǻ and 
C8B Cl3B Cl3iii angle 127.77(10)°] and the -  stacking 
between aromatic rings (with a rings centroids separations of 
3.597Ǻ).  
 The synthesis of co-crystals of 5a,bwas carried out 
viamechanochemical reactions between 1 and ammonium 
halides 3a,b.  Halide anions can work as polydentate XB 
acceptors and the number of formed interactions varies from 
one system to the other.  DSC titration methods wereused to 
determine the preferred pairing ratiosbetween 1and3a,b. DSC 
analyses of 1:1 and 3:1 mixtures of 1 and 3aboth showed 
multiple endothermicpeaks.A new peak at 67 °C, mismatching 
the starting components, was shown byboth mixture along with 
the melting of pure 3a (at 141 °C) in the 1:1 mixture and of 
pure 1a (at 111 °C) inthe 3:1 mixture.  This was suggesting that 
some excess starting component was present in both cases and 
that the preferred 1:3a pairing ratio in 5ais 2:1.  Indeed, a 
mixture with this exact composition showed a single 
endothermic peak at 67 °C.A similar DSC analysis revealed 
that also the pairing ratio for the complex5b(m.p.: 83 °C) was 
2:1. 
 FTIR spectroscopy on these halogen-bonded ionic co-
crystals showed red-shifted triple bond stretching modes from 
2187 cm-1in pure 1ato 2180 cm-1 in 5aandto 2175 cm-1 in 5b, 
suggesting the involvement of the iodoalkynyl fragment in the 
co-crystalsformation. The observed red-shiftstrend is also 
consistent with the chloride anion being a better XBacceptor 
than the iodide anion. 
 Very fewgood-quality single crystals of 5aand 5bwere 
obtained by adding finely ground powders of the complexes 
obtained in the mechanochemical syntheses toquasi-saturated 
methanolsolutions of the starting compounds (2:1 molar ratio).  
Their single crystal structure determination confirmed the 
formation of a new supramolecular adduct composed by two 
molecules of haloprogin and one molecule of ammonium 
halide. 
 The asymmetric unit of 5a iscomprisedby one molecule 
of1and half molecule of 3awhich lies on a twofold axis.The 
complex is assembled thanks to strong XBs occurring between 
the iodine atom of1 and the iodide anionof the organic salt, 
which behaves ad a bidentate XBacceptor(Figure 6,left). The 
distance between the XBdonor and acceptor is 3.3977(4)Å 
(82% reduction of the svdWr of I and the Pauling ionic radius 

























Figure 6.Bonding pattern around halide anions in the cocrystals 5a (left) and 
5b (right).  XBs and HBs are pictured as black dotted lines. In both 5a and 5b 
the N atom of the tetra n-butylammonium cation lies on a twofold axis. 
Colour code as in Figure 1. 
 
is 175.73(12)°, both these values indicating the occurrence of a 
strong XB. The halide coordination sphere is completed by four 
HB contacts with H atoms belonging to the cation alkyl chains. 
 The crystal structure of 5b(Figure 6,right)is similar to 5a.  
The chloride ion is halogen-bonded to iodineatom with a 
I1∙∙∙Cl4 distance of 3.0427(5)Å (80% reduction of the svdWr of 
I and the Pauling ionic radius of Cl‾) and C1 I1∙∙∙Cl4‾ angle of 
176.00(4)°(Figure 6,right). This remarkably short distance 
confirms that the C I∙∙∙Cl‾ synthon is stronger that the 
C I∙∙∙I‾one, in nice agreement with the differences in melting 
point and red-shift of triple bond stretching modesin FTIR 
spectra.  In this case too, the halide anioncoordination sphere is 
completed by HB interactions involving the cation alkyl chains, 
but only two such interactions are present. 
 
Solid-State NMR studies 
Further characterization of the bulk materials was performed by 
multinuclear Solid-State NMR studies (SSNMR).  Different 
from HB,24,25 only in recent years SSNMR has been applied to 
investigate XB.26This hasbeen done mainly by analysing 
directly involved nuclei such as 19F, 14/15N, 35Cl, 81Br, and 
127I,27but also neighbouring atoms have been considered.28For 
instance, it was shown that13C resonances of halogen-bonded 
carbon atoms are broadened or even split due to a 2ndorder 
effect of dipolar coupling to the quadrupolar 35/37Cl (both spin 
3/2) or 127I (spin 5/2) nuclei,29 thus confirming the proposed 
assignment for these signals.  
 Owing to the intrinsic difficulty of achieving relevant 
quantities of 1b and 1c polymorphs, here we report only the 
SSNMR characterization of 1a and of the three co-crystals 4, 
5a, and 5b.The 13C Cross Polarization Magic Angle 
Spinning(CPMAS)spectrum of 1a is characterized by a broad 
resonance at 14.4 ppm assigned to C1(Figure 7).  This carbon 
gives a signal at 6.97 ppm in CDCl3 solution and at 18.58 ppm 
in C6D5N solution, indicating that the C1 chemical shift moves 
upfield when the iodine atom is halogen-bonded.4The observed 
chemical shift in 1a is in agreement with the presence of a XB 
between the iodine atom and the π electrons of the triple bond.  
While the details of the relationship between XB strength and 





















Figure 7.13C (100.65 MHz) CPMAS spectra (region of the C1 resonance) of 
1aand cocrystals 4 and 5a,brecorded at the spinning of 12/13 kHz. Asterisks 
and triangles mark spinning sidebands and unreacted 3a, respectively.  
the small difference between the chemical shift of1ain the solid 
and its chloroform solution (where no, or negligibly weak, XBs 
are present), may suggest the I∙∙∙  electrons in 1a is a medium-
strength XB. 
 It is expected the I N XB, present in co-crystal 4, is 
stronger than the I electrons XB, occurring in 1a, and the C1 
signal in crystalline 4is at 25.1 ppm (Figure 7). The presence of 
the I N XB in this co-crystalisfurtherconfirmed by the 15N 
(40.55 MHz) CPMAS spectra (see ESI) showing that the 
pyridine nitrogen moves from 289.0(in pure 2) to 273.7 ppm(in 
co-crystal 4).  
 As far as the SSNMR spectra of the ionic co-crystals 5aand 
5b are concerned, the C1 signal is found at 31.6 and 33.0 ppm 
in 3aand 3b complexes, respectively(Figure 7).  Thesechemical 
shifts are consistent with the formation of C-I∙∙∙Y‾ synthons 
(Y=I, Cl) and they may also suggest that chloride anionsare 
better XBacceptors than the iodide anion and that halides are 
better XB acceptors than neutral pyridine species.   
 
Conclusions 
In summary, herein we have reported a polymorph and co-
crystal screening study of theantifungalagent haloprogin(1,2,4-
trichloro-5-[(3-iodoprop-2-yn-1-yl)oxy]benzene, 1),a well-
known halogenated API.  We have described three polymorphs 
and three co-crystals involving both neutral and ionic 
CCFs.These are the first crystal structures reported in the CSD 











 In the described cases, the 1-iodoalkyne moiety has been 
shownto be a very good  XBdonor.  In the crystallization of 
pure haloprogin, the iodine atom probes the accessible electron 
donor sites and the three obtained polymorphs result from this 
sampling process, the iodine atom binding to the -electrons of 
the triple bond (in 1a), one chlorine atom (in 1b), and one 
chlorine and oxygen atom (in 1c).  When more effective 
electron donor sites are made accessible by the presence of the 
CCFs 2 and 3a,b, co-crystals are formed wherein the iodine 
atom binds to the pyridine nitrogen (in 4) and the halide anions 
(in 5a,b). 
 The obtained crystals have been fully characterized with 
various techniques (single crystal and powder X-ray 
crystallography, solid-state NMR, IR, and DSC), which have all 
shown that XB is a key interaction responsible for the adopted 
architectures in the described systems.The strategy reported in 
this paper is general and may find wide application in the 
design of new pharmaceutical polymorphs and co-crystals 
involving halogenated active pharmaceutical ingredients.  
 
Acknowledgements 
P.M., G.R., and G.T. thank Fondazione Cariplo (grant number 
2010-1351) and MIUR (projects PRIN 2010–2011, grant 
numbers 2010CX2TLM_004 and 2010ERFKXL_005) for 
financial support.  
 
Notes and references 
aNFMLab-Laboratory of Nanostructured Fluorinated Materials 
(NFMLab), Department of Chemistry, Materials, and Chemical 
Engineering “Giulio Natta”, Politecnico di Milano, Via L. 
Mancinelli 7, 20131 Milan, Italy. 
bDepartment of Chemistry, Università di Torino, Via P. Giuria 7, 
10125 Torino, Italy. 
†Electronic Supplementary Information (ESI) available: Synthetic 
procedures, DSC plots, FTIR spectra, powder XRD plots, and 
details of the CSD search. See DOI:10.1039/b000000x. 
 
                                                          
1 (a) W. Jones, W. D. S. Motherwell and A. V. Trask, MRS Bulletin, 
2006, 31, 875; (b) P. Vishweshwar, J. A. McMahon, J. A. Bis and M. 
J. Zaworotko, J. Pharm. Sci., 2006, 95, 499; (c) N. Issa, P. G. 
Karamertzanis, G. W. Welch and S. L. Price, Cryst. Growth 
Des.,2009, 9, 442; (d) C. B. Aakeröy, S. Forbes and J. Desper, J. Am. 
Chem. Soc., 2009, 131, 17048; (e) C. B. Aakeröy, A. B. Grommet 
and J. Desper, Pharmaceutics,2011, 3, 601; (f) D. R. Weyna, M. L. 
Cheney, N. Shan, M. Hanna, Ł. Wojtas and M. J. Zaworotko, 
CrystEngComm,2012, 14, 2377; (g) F. L. F. Soares and R. L. 
Carneiro, Cryst. Growth Des.,2013, 13, 1510.4  
2 A. Lemmerer, J. Bernstein, J. Chem. Crystallogr.,2011, 41, 991. 
3
 A halogen bond occurs when there is evidence of a net attractive 
interaction between an electrophilic region associated with a halogen 
atom in a molecular entity and a nucleophilic region in another, or the 
same, molecular entity. G. R. Desiraju, P. S. Ho, L. Kloo, A. C. Legon, 
R. Marquardt, P. Metrangolo, P. Politzer, G. Resnati and K. Rissanen, 
Pure Appl. Chem. 2013, 85, 1711. 
 
 
4 M. Baldrighi, G. Cavallo, M. R. Chierotti, R. Gobetto, P. Metrangolo, T. 
Pilati, G. Resnati, and G. Terraneo, Mol. Pharm., 2013, 10, 1760. 
5 (a) E. F. Harrison, P. Zwadyk, R. J. Bequette, E. E. Hamlow, P. A. 
Tavormina and W. A. Zygmunt, Applied Microbiology, 1970, 19, 
746; (b) E. F. Harrison and W. A. Zygmunt, Can. J. Microb., 1974, 
20, 1241; (c) E. Gregori-Puigjané, V. Setola, J. Hert, B. A. Crews, J. 
J. Irwin, E. Lounkine, L. Marnett, B. L. Roth and B. K. Shoichet, 
Proc. Natl. Acad. Sci. U.S.A., 2012, 109, 11178; (d) G. Stuettgen, J. 
Mueller and W. Roelz, Antimycotic preparations in a cream or 
ointment base, 1983, GB2116425A; (e) I. R. McGraw, Use of 
Haloprogin to treat Herpes Labialis, 1984, US4434183; (f) J. 
Ponikau, Use of antifungal agents for the topical treatment of fungus-
induced mucositis, 2007, EP1024814. 
6 F. H. Allen, Acta Crystallogr. B, 2002, 58, 380. 
7 C. B. Aakeröy, M. Baldrighi, J. Desper, P. Metrangolo and G. 
Resnati, Chem. Eur. J., 2013, 19, 16240. 
8 T. Clark, M. Hennemann, J. S. Murray and P. Politzer, J. Mol. Model. 
2007, 13, 291. 
9 (a) P. Metrangolo, F. Meyer, T. Pilati, G. Resnati and G. Terraneo, 
Angew Chem. Int. Ed. 2008, 47, 6114; (b) M. Fourmigué, Curr. Opin. 
Solid State Mater. Sci., 2009, 13, 36; (c) T. M. Beale, M. G. 
Chudzinski, M. G. Sarwar and M. S. Taylor, Chem. Soc. Rev., 2012, 
42, 1667; (d) M. Erdélyi, Chem. Soc. Rev., 2012, 41, 3547; (e) F. 
Meyer and P. Dubois CrystEngComm,2013, 15, 3058; (f) G. Cavallo, 
A. Priimagi, P. Metrangolo and G. Resnati, Acc. Chem. Res., 2013, 
46, 2686; (g) R. W.Troff,T. Makela, F. Topic, A. Valkonen, K. 
Raatikainen, K. Rissanen, Kari, Eur. J. Org. Chem.2013, 9, 1617.  
10 C. Perkins, S. Libri, H. Adams and L. Brammer, CrystEngComm, 
2012, 14, 3033. 
11 D. Braga, F. Grepioni, L. Maini, D. Capucci, S. Nanna, J. Wouters, L. 
Aerts and L. Quéré, Chem. Commun., 2012, 48, 8219. 
12 GRAS (Generally Recognized As Safe) Notices: 
http://www.cfsan.fda.gov/∼rdb/opa-gras.html. 
13 J. Fellig, J. R. Barnes, A. I. Rachlin, J. P. O’Brien and A. Focella, J. 
Agr. Food Chem., 1970, 18, 78. 
14 Saint Plus, v.6.01, Bruker Analytical X-ray, Madison, WI, 1999. 
15 (a) Sheldrick, G. M. SADABS: Empirical Absorption Correction 
Program, University of Gottingen, Germany, 2001. Based upon the 
method of Blessing; (b) R. H. Blessing, Acta Crystallogr. A, 1995, 
51, 33. 
16 APEXII v2009. 5-1, © 2009, Bruker Analytical X-ray Systems, 
Madison, WI 
17 G. M. Sheldrick, Acta Crystallogr. A, 2008, 64, 112. 
18 L. J. Farrugia, J. Appl. Crystallogr.,1999, 32, 837. 
19 Mercury 3.1, © CCDC 2001-2012. 
20 Spartan’10, Wavefunction Inc., Irvine, CA. 
21 C. J. Adams and L. E. Bowen, Dalton Trans., 2005, 2239; T. Graening, 
V. Bette, J. Neudorfl, J. Lex and H.-G. Schmalz, Org. Lett., 2005, 7, 
4317; A.-L. Barres, A. El-Ghayoury, L. V. Zorina, E. Canadell, P. 
Auban-Senzier and P. Batail, Chem. Commun., 2008, 44, 2194. 
22 A. Bondi, J. Phys. Chem., 1964, 68, 441. 
23 (a) A.B. Sheremetev, J.L .Shamshina, D.E. Dmitriev, D.V. Lyubetskii 





Setifi, S. Golhen, T. Imakubo, R. Lescouezec, F. Lloret, M. Julve and R. 
Swietlik, Comptes Rendus Chimie, 2005, 8, 1286; (c) K.D. Scherfise, F. 
Weller and K. Dehnicke, Z. Naturforsch.,B: Chem.Sci., 1985, 40, 906. 
24 (a) M. R. Chierotti, and R. Gobetto, Chem. Commun., 2008, 14, 1621; 
(b) S. P. Brown, Solid State Nucl. Magn. Reson., 2012, 41, 1; (c) X. 
Filip, I. G. Grosu, M. Miclaus, and C. Filip, CrystEngComm, 2013, 15, 
4131. 
25 (a) J. P. Bradley, C. J. Pickard, J. C. Burley, D. R. Martin, L. P. Hughes, 
S. D. Cosgrove and S. P. Brown, J. Pharm. Sci., 2012, 101, 1821; (b) M. 
U. Schmidt, J. Bruning, J. Glinnemann, M. W. Hutzler, P. Morschel, S. 
N. Ivashevskaya, J. van de Streek, D. Braga, L. Maini, M. R. Chierotti 
and R. Gobetto, Angew. Chem. Int. Ed., 2011, 50, 7924. 
26 (a) C. M. Widdifield, G. Cavallo, G. A. Facey, T. Pilati, J. Lin, P. 
Metrangolo, G. Resnati and D. L. Bryce, Chem. Eur. J. 2013, 19, 11949; 
(b) J. Viger-Gravel, S. Leclerc, I. Korobkov and D. L. Bryce, 
CrystEngComm., 2013, 15, 3168. 
27  (a) R. J. Attrell, C. M. Widdifield, I. Korobkov, and D.L. Bryce, Cryst. 
Growth Des., 2012, 12, 1641; (b) J. Viger-Gravel, I. Korobkov and D. L. 
Bryce, Cryst. Growth Des., 2011, 11, 4984; c) M. G. Chudzinski, C. A. 
McClary and M. S. Taylor, J. Am. Chem. Soc., 2011, 133, 10559. 
28 (a) Nonappa; Lahtinen, M.; Kolehmainen, E.; Haarala, J.; Shevchenko, 
A.; Cryst. Growth Des., 2013, 13 346; (b) C. Lemouchi, C. S. 
Vogelsberg, L. Zorina, S. Simonov, P. Batail, S. Brown and M. A. 
Garcia-Garibay, J. Am. Chem. Soc., 2011, 133, 6371. 
29 C. Pettinari, C. Di Nicola, F. Marchetti, R. Pettinari, B. W. Skelton, N. 
Somers, A. H. White, W. T. Robinson, M. R. Chierotti, R. Gobetto, and 
C. Nervi, Eur. J. Inorg. Chem. 2008, 1974. 
Electronic Supporting Information (ESI)
Polymorphs and cocrystals of Haloprogin: An antifungal agent
Michele Baldrighi,a Davide Bartesaghi,a Gabriella Cavallo,a Michele R. Chierotti,b Roberto 
Gobetto, b  Pierangelo Metrangolo,*a Tullio Pilati,a Giuseppe Resnati,*a and Giancarlo 
Terraneo*a
a NFMLab-Laboratory of Nanostructured Fluorinated Materials (NFMLab), Department of 
Chemistry, Materials, and Chemical Engineering “Giulio Natta”, Politecnico di Milano, Via 
L. Mancinelli 7, 20131 Milan, Italy.
b Department of Chemistry, Università di Torino, Via P. Giuria 7, 10125 Torino, Italy.
1
Electronic Supplementary Material (ESI) for CrystEngComm.
This journal is © The Royal Society of Chemistry 2014
Index:
1. Synthesis of (1,2,4-trichloro-5-[(3-iodoprop-2-yn-1-yl)oxy]benzene, 1)  
1.1.  Synthesis of 1,2,4-trichloro-5-(prop-2-yn-1-yloxy)benzene (A).
1.2.  Synthesis of 1,2,4-trichloro-5-((3-iodoprop-2-yn-1-yl)oxy)benzene (1).
1.3.  Crystallization experiments.
2. Thermal analysis (DSC plots)
2.1.  DSC plot of polymorphs 1a and 1b.
2.2.  DSC plots of co-crystals 4, 5a, and 5b.
3. Vibrational spectra (FTIR)
3.1.  FTIR spectrum of 1a.
3.2.  FTIR spectrum of 1b.
3.3.  FTIR spectrum of 4.
3.4.  FTIR spectrum of 5a.
3.5.  FTIR spectrum of 5b.
4. Powder XRD 
4.1.  PXRD pattern of 1a.
4.2.  PXRD pattern of mixture of polymorphs 1a and 1b.
4.3. PXRD pattern of 4.
4.4.  PXRD pattern of 5a.
4.5.  PXRD pattern of 5b. 
5. SSNMR
5.1.  Chemical shift assignments.
5.2.  Full 13C CPMAS spectra of 5b, 3b, 5a, 3a, 4, 2, and 1a from top to bottom, 
respectively.
5.3. 15N CPMAS spectra. 
6. Cambridge Structural Database (CSD) Search
6.1.  XB contacts involving iodoethynyl moiety and -electrons of triple bond.
2
Synthesis of (1,2,4-trichloro-5-[(3-iodoprop-2-yn-1-yl)oxy]benzene, 1) 
1.1. Synthesis of 1,2,4-trichloro-5-(prop-2-yn-1-yloxy)benzene (A):  in a round bottom flask 
equipped with a magnetic stirrer were mixed 1.0 g of 2,4,5-trichlorophenol (5.06 mmol), 662.6 
mg of 3-bromo-1-propyne (5.57 mmol) and 768.6 mg (5.57 mmol) of potassium carbonate 
dissolved in 8 mL of acetone.  The reaction was stirred under reflux for 5 hours, and allowed to 
cool down, then the solids were filtered and the solution was evaporated under vacuum, giving 
1.165 g (98%) of pure product.  M.p. 63-64 °C; FTIR (selected bands):3092, 2984, 2122, 1476, 
1457, 1235, 1080, 1024, 870, 672 cm-1; 1H NMR (400 MHz, CDCl3) δ (ppm) 7.47 (s, 1H), 7.18 
(s, 1H), 4.76 (d, J = 2.4 Hz, 2H), 2.59 (t, J = 2.4 Hz, 1H).  13C NMR (101 MHz, CDCl3) δ (ppm) 
152.32, 131.31, 131.28, 125.55, 122.83, 116.23, 77.24, 77.12, 57.52.
1.2. Synthesis of 1,2,4-trichloro-5-((3-iodoprop-2-yn-1-yl)oxy)benzene (Haloprogin, 1): a 
round bottom flask equipped with a magnetic stirrer was charged with 200 mg of A (0.85 mmol) 
dissolved in 15 mL of methanol.  A solution of iodine (284 mg, 1.12 mmol) in methanol and a 
10% water solution of sodium hydroxide (77.5 mg, 1.94 mmol) were dropped simultaneously 
over 20 minutes.  The reaction was stirred overnight, then 20 mL of water were added, causing 
the formation of a white precipitate.  The mixture was stirred for 30 min, then the solid material 
was recovered by filtration, washed two times with cold water and dried over a nitrogen flux, 
affording 221 mg of the pure product (72% yield).  M.p.: 111-112 °C; FTIR (selected bands): 
2187, 1581, 1472, 1453, 1232, 1077, 1028, 866, 724, 681 cm-1. 1H NMR (400 MHz, CDCl3) δ 
(ppm) 7.46 (s, 1H), 7.15 (s, 1H), 4.89 (s, 2H). 13C NMR (101 MHz, CDCl3) δ 152.20 (C4), 
131.22(C8), 131.13(C6), 125.51(C7), 122.73 (C5), 116.16 (C9), 87.64 (C2), 58.91 (C3), 6.97 
(C1).  13C NMR (101 MHz, C5D5N) δ (ppm) 152.65 (C4), 131.14 (C8), 131.10 (C6), 124.62 
(C7), 122.40(C5), 116.14 (C9), 86.78(C2), 59.06 (C3), 18.58 (C1).
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1.3. Crystallization experiments. 
General crystallization procedure: in a 2.5 mL glass vial 10 mg of 1 (0.027 mmol) 
were dissolved in 1.5 mL of the selected organic solvent or solvent mixture (see below). 
The vial was left open under a hood at room temperature in order to allow the evaporation 
of the solvent.  The identification of the obtained form was performed by checking the 
unit cell parameters of selected crystals.






CHCl3/MeOH 9:1; 1:1; 1:9 1a
CHCl3/MeOH/CH3CO2Na 1b and 1c
4
1. Thermal analysis (DSC plots)
2.1. DSC of polymorph 1a (left) and 1b (right).
  
2.2. DSC of 4 (left), 5a (mid), and 5b (right).
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3. Vibration spectra (FTIR)
3.1. FTIR spectrum of 1a. 
3.2. FTIR spectrum of 1b. 
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4.1. PXRD pattern of polymorph 1a.
Red line:  experimental powder pattern of 1a.  Blue line:  simulated from single crystal of 1a. 
10
4.2. PXRD pattern of mixture of polymorphs 1a and 1b. 
Red line:  experimental powder pattern of 1b  and  1a mixture.  Black line:  simulated from 
single crystal of 1b.
Red line:  experimental powder pattern of 1b  and  1a mixture.  Blue line:  simulated from single 
crystal of 1a.
Red line: experimental powder pattern of 1b  and  1a mixture.  Blue line:  simulated from single 
crystal of 1a. Black line:  simulated from single crystal of 1b.
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Region between 5.5° and 19° (2 theta). Red line: experimental powder pattern of 1b  and  1a 
mixture.  Blue line:  simulated from single crystal of 1a. Black line:  simulated from single 
crystal of 1b.
The polymorph 1b was obtained when a chloroform solution of haloprogin was allowed to 
slowly diffuse into a saturated methanol solution of sodium acetate and the resulting solvents 
mixture was slowly evaporated at room temperature. Few crystals of 1b were obtained along 
with massive quantities of 1a. The samples used in PXRD experiment were obtained by selecting 
the 1b crystals over 1a. Therefore since 1b crystals were always obtained along with large 
quantities of 1a the reported powder patterns show a mixture of 1b and 1a. 
The number of crystals for the polymorph 1c were very few (much lower than 1b) and extremely 
unstable. The low stability and the insufficient amount of this sample did not allow for the 
obtainment of PXRD data.
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4.2. PXRD pattern of co-crystal 4.
Red line:  experimental powder pattern of 4. Blue line:  simulated from single crystal of 4.  
The sample of 4 was prepared by slow evaporation and then was finely ground.
13
4.3. PXRD pattern of co-crystal 5a.
Red line:  experimental powder pattern of 5a.  Blue line: simulated from single crystal of 5a.
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4.4. PXRD pattern of co-crystal 5b.
Red line:  experimental powder pattern of 5b.  Blue line:  simulated from single crystal of 5b.
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5 SSNMR
5.1. Chemical shift assignments
Table S1. 13C and 15N chemical shift assignments for pure reagents (1a, 2, 3a, and 3b), 
and for the 4, 5a, and 5b co-crystals.
Atom note 2 3 3B 1A 4 5A 5B
C1A CHa/CH2b 149.6/148.2/146.9 61.3 56.9/57.3/57.9 151.2/149.8 58.0/58.3 57.3/62.4
C2A CHa/CH2b 123.1/121.5 26.3 23.9/24.3/24.7/25.7 122.4 23.7/24.5 24.4/25.7
C3A Cqa/CH2b 146.9 21.3 19.9/21.0 146.4 20.3/22.0 20.2/21.0
C4A CH3 - 14.1/15.0/15.2 14.5/14.8/15.0/15.3 15.5/16.2 14.1/14.9/15.8/16.3
C1 Cq 14.4 25.1 31.6 33.0
C2 Cq 91.1 84.6 81.5 83.1/86.2
C3 CH2 61.3 58.9 59.0 60.3/60.9
C4 Cq 153.7 152.5 153.1 152.2/152.9
C5 Cq 119.5c/122.3c 120.8 120.5c/123.3c 121.0c/121.7c
C6 CH 129.9 129.8 131.9 130.5/131.2
C7 Cq 124.3/127.6c/sh 126.5 123.7c/128.1c 124.0/124.6
C8 Cq 135.4 134.8 134.3 133.0
C9 CH 115.5 114.6 114.4 114.3/115.0
N Nt 289.0 - - - 273.7 - -
a Bipyridine. b Tetra n-butylammonium iodide or chloride. c Two values observed due to a second-order effect of dipolar 
coupling to the quadrupolar chlorine-35/37 (both spin 3/2) or iodine-127 (spin 5/2) nuclei which splits or broadens the 
signals.
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5.2. Full 13C CPMAS spectra of 5b, 3b, 5a, 3a, 4, 2, and 1a from top to bottom, 
respectively. 
13C (100.65 MHz) CPMAS spectra of all reagents and co-crystals were recorded at the spinning 
of 12/13 kHz.  Asterisks and triangles mark spinning sidebands and unreacted 3a, respectively. 









5.3. 15N CPMAS spectra. 
4
2
15N (40.55 MHz) CPMAS spectra of pure 2 (bottom) and of 4 (top) recorded at the spinning of 9 
kHz.
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6 Cambridge Structural Database (CSD) Search, version 5.34, update 1 (Nov. 
2012)
6.1. XB contacts involving the iodoethynyl moiety and -electrons on triple bond.
The CSD search has been performed on the fragment reported below.  Restrictions: 3D 
coordinates, no disordered structure, no errors, no polymeric structure.  Angle between C-
I…centroid of triple bond (C*) between 140° and 180°, distance between I and centroid of 
triple bond between 2 Å and 3.8 Å.





N° of hits: 13 
Distance I∙∙∙C* median value: 3.466 Å.
Angle C-I∙∙∙C* median value: 165.6°
CSD Refcode
AVIYEK
BAMPIQ
BOBGUV
DIACET
ELIMES
QAQTOS
RAXKOR
RETRIR
SIVYEC
TOJBUQ
XASWOD
XUNRII
YAPCUP
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